Aishat Afuye
0000-0002-5751-3283
5 papers found
Refreshing results…
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
Missing publications? Search for publications with a matching author name.